Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 130, Issue 12, Pages -Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI125297
Keywords
-
Categories
Funding
- NIH/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [R21AI127404]
- National Research Foundation of Korea (NRF) - Korean government (MSIT) [NRF2018R1A5A1025077]
- Life Sciences Fellowship at the University of Missouri-Columbia
Ask authors/readers for more resources
Chronic viral infections are often established by the exploitation of immune-regulatory mechanisms that result in nonfunctional T cell responses. Viruses that establish persistent infections remain a serious threat to human health. Sphingosine kinase 2 (SphK2) generates sphingosine 1-phosphate, which is a molecule known to regulate multiple cellular processes. However, little is known about SphK2's role during the host immune responses to viral infection. Here, we demonstrate that SphK2 functions during lymphocytic choriomeningitis virus Cl 13 (LCMV Cl 13) infection to limit T cell immune pathology, which subsequently aids in the establishment of virus-induced immunosuppression and the resultant viral persistence. The infection of Sphk2-deficient (Sphk2(-/-)) mice with LCMV Cl 13 led to the development of nephropathy and mortality via T cell-mediated immunopathology. Following LCMV infection, Sphk2(-/-) CD4(+) T cells displayed increased activity and proliferation, and these cells promoted overactive LCMV Cl 13-specific CD8(+) T cell responses. Notably, oral instillation of an SphK2-selective inhibitor promoted protective T cell responses and accelerated the termination of LCMV Cl 13 persistence in mice. Thus, SphK2 is indicated as an immunotherapeutic target for the control of persistent viral infections.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available